These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1108 related items for PubMed ID: 15950109

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.
    Hernández-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, García-Pagán JC.
    Hepatology; 2004 Nov; 40(5):1197-202. PubMed ID: 15486923
    [Abstract] [Full Text] [Related]

  • 5. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.
    Cejna M, Peck-Radosavljevic M, Thurnher S, Schoder M, Rand T, Angermayr B, Lammer J.
    Cardiovasc Intervent Radiol; 2002 Nov; 25(5):365-72. PubMed ID: 11981612
    [Abstract] [Full Text] [Related]

  • 6. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D, Patch D, Dick R, Grosso M, Rousseau H, Otal P, Goffette P, Heinecke A, Drees M, Domschke W, Menzel J.
    Cardiovasc Intervent Radiol; 2002 Nov; 25(6):506-12. PubMed ID: 12183763
    [Abstract] [Full Text] [Related]

  • 7. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.
    Maleux G, Nevens F, Wilmer A, Heye S, Verslype C, Thijs M, Wilms G.
    Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.
    Ockenga J, Kroencke TJ, Schuetz T, Plauth M, Kasim E, Petersein J, Schmidt HH, Lochs H.
    Scand J Gastroenterol; 2004 Oct; 39(10):994-9. PubMed ID: 15513340
    [Abstract] [Full Text] [Related]

  • 11. Intravascular ultrasound-guided direct intrahepatic portacaval shunt: midterm follow-up.
    Petersen B, Binkert C.
    J Vasc Interv Radiol; 2004 Sep; 15(9):927-38. PubMed ID: 15361560
    [Abstract] [Full Text] [Related]

  • 12. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
    Wettstein M, Lüthen R, Cohnen M, von Wrisberg F, Mödder U, Häussinger D.
    Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
    [Abstract] [Full Text] [Related]

  • 13. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
    Rössle M, Siegerstetter V, Euringer W, Olschewski M, Kromeier J, Kurz K, Langer M.
    Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
    [Abstract] [Full Text] [Related]

  • 14. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA, Karnel F, Georgieva B, Tauss J, Portugaller H, Deutschmann H, Berghold A.
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [Abstract] [Full Text] [Related]

  • 15. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Mar; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 16. Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax.
    LaBerge JM.
    Clin Liver Dis; 2006 Aug; 10(3):583-98, ix. PubMed ID: 17162229
    [Abstract] [Full Text] [Related]

  • 17. [The impact of secondary insertion of ePTFE-coated stent on sustainable TIPS patency].
    Jirkovský V, Fejfar T, Safka V, Hůlek P, Chovanec V, Krajina A, Raupach J, Lojík M.
    Vnitr Lek; 2007 Feb; 53(2):123-8. PubMed ID: 17419172
    [Abstract] [Full Text] [Related]

  • 18. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
    Charon JP, Alaeddin FH, Pimpalwar SA, Fay DM, Olliff SP, Jackson RW, Edwards RD, Robertson IR, Rose JD, Moss JG.
    J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F, Baez AL, Pandula R, Walser E, Lau DT.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.